The modified HALP (m-HALP) score was a significant predictor of 3-month mortality in patients with acute heart failure (AUC 0.687, p=0.002), whereas the classical HALP score was not adequate.
Observational (n=101)
No
Do the HALP and modified HALP scores predict 1-week and 3-month mortality in patients presenting to the emergency department with acute heart failure?
The modified HALP score, along with thrombocytopenia and increased NLR, may serve as a potential independent prognostic index for predicting 3-month mortality in patients with acute heart failure.
Effect estimate: AUC 0.687
p-value: p=0.002
OBJECTIVE: To investigate the relationship between the HALP score (haemoglobin, albumin, lymphocyte, and platelet), the modified HALP (m-HALP) score, and prognosis in patients presenting to the emergency department (ED) with acute heart failure (AHF). STUDY DESIGN: A Descriptive study. PLACE AND DURATION OF STUDY: The Emergency Department of Balikesir University Hospital, Turkey, between January 2019 and September 2021. METHODOLOGY: Patients diagnosed with AHF were divided into two groups, namely survivors and non-survivors. Both groups were compared in terms of HALP, m-HALP, PLT, NLR and PLR values ROC curve analysis was performed to evaluate their diagnostic performances in discriminating between one-week and three-month mortality. Youden J index was used to obtain the optimal cut-off value. RESULTS: The mean age of 101 patients included in the study was 73.15±10.19 years, with 51.5% (n=52) females, and 48.5% (n=49) males. The 1-week and 3-month mortality rates were 11.9% and 38.6%, respectively. For 1-week (p=0.018) and 3-month (p=0.006) mortality, platelet was significantly higher in the survivor group than in the non-survivor group. The m-HALP score and the NLR were found to be good predictors for 3-month mortality (p=0.002 and 0.016 respectively). The optimal cut-off values of m-HALP score, the platelet, and the NLR in predicting 3-month mortality were found as ≤1081723.5, ≤217, and >8.4. The area under curve (AUC) values were found as 0.687, 0.663, and 0.643, respectively. The sensitivity of the m-HALP score, the platelet, and the NLR were 76.92, 66.67, and 46.15, and the specificity values were 56.45, 67.74, and 79.03, respectively. CONCLUSION: The m-HALP score was found to be a potential independent prognostic index for patients with AHF. The classical HALP score was not adequate to predict early and late prognosis. In addition, thrombocytopenia and increased NLR were associated with increased mortality in patients with AHF. KEY WORDS: Acute heart failure (AHF), HALP score, m-HALP score, Neutrophil lymphocyte ratio (NLR), Platelet lymphocyte ratio (PLR), Platelet (PLT).
Kocaoğlu et al. (Wed,) conducted a observational in Acute heart failure (n=101). HALP score and modified HALP (m-HALP) score was evaluated on 3-month mortality (AUC 0.687, p=0.002). The modified HALP (m-HALP) score was a significant predictor of 3-month mortality in patients with acute heart failure (AUC 0.687, p=0.002), whereas the classical HALP score was not adequate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: